XPEV - MYOK TEF among premarket gainers
MyoKardia (MYOK) +59% as Bristol to acquire the company for $225/Share.Kosmos Energy (KOS) +50% as company closed a Gulf of Mexico facility with Beal Bank USA and Trafigura Trading LLC.Enlivex Therapeutics (ENLV) +49%.Corvus Pharmaceuticals (CRVS) +38% on co-founding China-based Angel Pharmaceuticals.Humanigen (HGEN) +34%.Eidos Therapeutics (EIDX) +31% as BridgeBio Pharma to acquire remaining 36.3% shares in the company.ImmunoGen (IMGN) +29% after IMGN632 nabs accelerated review for rare blood cancer.Neptune Wellness Solutions (NEPT) +19% after company inks distribution deal with Kraft Heinz.Biocept (BIOC) +16% after announcing results from a prospective study comparing its Target Selector™ cerebrospinal fluid testing.Livent (LTHM) +15%.GAN (GAN) +14% after company signed long-term agreement with Wynn Resorts.Magal Security Systems (MAGS) +11% as its consortium bags $20M orders.Lithium Americas (LAC) +10%.CTI BioPharma (CTIC) +9%.Moxian (MOXC) +8%.Cytokinetics (CYTK) +8% after company announces data from two rresentations at the HFSA.Blonder Tongue Laboratories (BDR) +8%.FSD Pharma (HUGE) +8% after company begins phase 2 clinical trial to evaluate FSD201.XPeng (XPEV) +8% on announcing vehicle delivery nos in Sept. and Q320.Net Element (NETE) +8%.Evogene (EVGN) +8%.Solid Biosciences
For further details see:
MYOK, TEF among premarket gainers